To examine rest-activity circadian rhythm (RAR) and cognitive decline in older men. (2005-06 and 2007-09). Wrist actigraphy was used to measure 24-hour activity counts at baseline. RAR variables included amplitude (strength of activity rhythm), mesor (mean activity level), pseudo F-statistic (overall circadian rhythm robustness), and acrophase (time of daily peak activity).
RESULTS:
After an average of 3.4 AE 0.5 years, men with lower amplitudes, mesors, and pseudo F-statistics had greater decline in 3MS performance (amplitude: -0.7 points Q1 vs -0.5 points Q4, p<.001; mesor: -0.5 points Q1 vs -0.2 points Q4, p=.01; pseudo F-statistic: -0.5 points Q1 vs -0.3 points Q4, p<.001). Lower amplitudes and pseudo-F statistics were associated with greater odds of clinically significant cognitive decline (≥5-point decrease) (amplitude Q1 vs. Q4: odds ratio (OR)=1.4, 95% confidence interval (CI)=1.0-1.9; pseudo-F statistic Q1 vs Q4: OR=1.4, 95% CI=1.0-1.9). Men with phase-advanced acrophase had greater odds of clinically significant cognitive decline (OR=1.8, 95% CI=1.2-2.8). Results were adjusted for multiple confounders. CONCLUSION: Several parameters of disrupted RAR (lower amplitude, pseudo F-statistic, mesor, phase-advanced acrophase) were associated with greater cognitive decline in older community-dwelling men. These findings contribute to a growing body of evidence suggesting that altered RARs are associated with cognitive decline in older adults. J Am Geriatr Soc 66:2136-2143, 2018.
Key words: cognitive decline; rest-activity rhythm; men C ircadian rhythms are critically involved in control of sleep-wake cycles and numerous physiological processes, including cognitive processing. 1 Aging is associated with altered rest-activity circadian rhythm (RAR), including lower amplitude (a measure of peak activity); 2 fragmentation or loss of rhythms; [3] [4] [5] [6] [7] [8] alterations in entrainment; and lack of sensitivity to phase resetting signals, including light and sleep medications. 9 The timing of activity also often shifts with age, resulting in changes to onset of sleepiness and wake time. 4 Despite these changes in circadian rhythm with aging, few studies have examined the association between disrupted RAR and cognition in older adults. [10] [11] [12] [13] In a study of older women, disrupted RAR, including low RAR amplitude, robustness, and delayed rhythm, were related to greater risk of mild cognitive impairment (MCI) and dementia. 14 Whether this same association exists in men has not been well studied.
The primary aim of the current study was to examine whether disrupted RAR is associated with cognitive impairment and decline in men enrolled in the multicenter Osteoporotic Fractures in Men (MrOS) study. We used validated wrist-worn actigraphs to longitudinally measure RAR measures related to cognitive decline in women (RAR amplitude, robustness, delayed rhythm) 14 . In secondary analyses, we further whether other sleep parameters found to be associated to cognitive decline in this cohort (sleep efficiency 15 , nocturnal hypoxemia, 16 level of activity (physical activity, hours worked)) would affect the association between circadian rhythm disruption and cognitive decline.
METHODS

Participants
During the MrOS baseline examination (March 2000-April 2002), 5,994 community-dwelling men aged 65 and older were enrolled at 6 clinical centers in the United States. 17, 18 To participate, men needed to be able to walk without assistance and could not have had a bilateral hip replacement.
The 19 and data on cognitive change from the Sleep Visit to MrOS Visit 2 or 3. Men were excluded from the longitudinal analysis if they had probable dementia at the Sleep Visit (Modified Mini-Mental State examination (3MS) score < 80 or taking a medication for dementia). No exclusion criteria were used for participation in MrOS Visit 2 or 3. There were 2,754 men in the final longitudinal analytical cohort (Figure 1 ).
In accordance with the Helsinki Declaration, all men provided written informed consent, and the institutional review board at each participating study site approved the study.
Actigraphy
At the Sleep Visit, RAR was examined using a wrist actigraph (SleepWatch-O, Ambulatory Monitoring, Inc., Ardsley, NY, USA). A piezoelectric linear accelerometer, which generated a voltage each time the actigraph was moved, measured movement. These voltages were gathered continuously and summarized over 1-minute epochs. Activity data were collected in the proportional integration mode (PIM). Men were asked to wear the actigraphs continuously for a minimum of three 24-hour periods in accordance with the Centers for Medicare and Medicaid Services (Current Procedural Technology code for actigraphy monitoring 95803). 20 An extension to the traditional cosine model was used to map the circadian activity rhythm to the activity data. This approach was based on the assumption that the MrOS RAR data have a cosinor-like distribution, but the modified cosine algorithm allowed for greater flexibility with the data than traditional cosinor methods. 21 Four RAR parameters were calculated. Amplitude (counts/min), a measure of the strength of activity rhythm, is the peak-to-nadir difference in activity at the point of greatest activity. Mesor (counts/ 1 Technically adequate, ≥ 72 hours of continuous data collection. RAR=rest-activity circadian rhythm; 3MS=Modified Mini-Mental State Examination. min) is the mean level of activity. Pseudo F-statistic (no unit) represents robustness of circadian activity rhythm, with higher pseudo-F values indicating stronger rhythms. Acrophase (portions of hours) is the time of day of peak activity. 22, 23 Circadian amplitude, mesor and pseudo-F statistic were examined based on quartile distributions. To allow for a potential U-shaped association, acrophase was examined in terms of deviation from the population mean (2:17 p.m.). Phase-advanced participants were defined as having an acrophase of more than 1.5 standard deviations (SDs) below the mean (<12:28 p.m.), and phase-delayed participants were defined as having an acrophase of more than 1.5 SDs above the mean (>4:06 p.m.). Participants in the reference category had an acrophase within 1.5 SDs of the mean (12:28-4:06 p.m.).
Participants completed sleep diaries for the time during which they wore the actigraph. Each minute the actigraph was worn was determined to be sleep or wake using the sleep scoring algorithm that the manufacturer provides. Sleep efficiency, a measure of sleep fragmentation, was defined as percentage of time in bed after lights off spent sleeping. 24 Values for sleep efficiency were averaged over all nights the participant wore the device.
Ascertainment of Cognitive Function
The 3MS is a global measurement of cognitive function; scores range from 0 to 100. Higher scores indicate better cognitive functioning, and a decrease in 3MS score represents cognitive decline. 25 Trained staff administered the 3MS at clinic visits.
Development of clinically significant cognitive decline from the Sleep Visit to Visit 3 (mean 3.4 AE 0.5 years later) was defined as a 5-point or more decline on the 3MS. 26 The Trail-Making Test Part B (TMT-B) was also used to assess cognitive function. 27 A shorter completion time indicates better cognitive functioning; an increase in completion time represents cognitive decline.
Other Measurements
All participants completed questionnaires at the Sleep Visit, including questions about demographic characteristics, selfreported medical history and health status, physical activity (Physical Activity Scale for the Elderly) 28 , hours worked in the past week (paid or volunteer), smoking, and alcohol use. The Geriatric Depression Scale was used to assess depressive symptoms. 29 All medications used within the preceding 30 days were entered into an electronic database, as described previously 30 Functional status was assessed based on 5 instrumental activities of daily living (IADLs). 31, 32 Self-reported caffeine intake was calculated based on caffeinated coffee, tea, and soda. 33 A comprehensive examination included measurements of body weight and height, which were used to calculate body mass index (BMI). Nocturnal hypoxemia was measured using polysomnography, as described previously, 25 defined as percentage of time during overnight sleep in which arterial oxygen saturation was less than 90% and categorized as less than 1% versus 1% or greater.
Statistical Analysis
Participant characteristics were compared according to amplitude and acrophase using chi-square tests for categorical variables and analysis of variance or Kruskal-Wallis tests for continuous variables.
The 3MS score was transformed (squared) to meet normality assumptions of the models used because of skewness. All results were back-transformed for presentation.
Random-effects models, which account for betweenparticipant variation and within-participant correlation of repeated outcomes, 34 were used to study the association between RAR and changes in cognition over time (repeated measures at Sleep Visit, Visit 2, and Visit 3). The randomeffect terms included the intercept and slope of the 3MS score over time. Variances and covariances were estimated using the restricted maximum likelihood method. Time was modeled as a continuous covariate. A quadratic term for time was considered to account for a nonlinear time trend; the interactions of the quadratic term and the RAR parameters were not significant, so time was modeled linearly. All continuous covariates were centered (value mean) for use in the models. Change in cognition is presented as average annualized change, calculated using coefficients derived from the random-effects models.
Logistic regression was used to assess the associations between the RAR parameters and clinically significant cognitive decline. Results are presented as odds ratios (ORs) and their 95% confidence intervals (CIs).
In models with the RAR predictors of amplitude, mesor, or pseudo F-statistic, quartile 4 served as the reference. A test for linear trend across quartiles was also completed. All models were minimally adjusted for age and clinic site. Additional covariates were selected for inclusion in a multivariable model by examining the univariate association between the covariate and the RAR parameters and the association with 3MS in age-adjusted models. Those covariates associated with a RAR parameter and an outcome at P<.10 were kept in all multivariable models (race, education, BMI, depression, history of comorbid conditions, IADL impairment, benzodiazepine use, antidepressant use, self-reported health status, alcohol use, caffeine intake, smoking status). Models were further adjusted for physical activity, sleep efficiency (sleep fragmentation), hours worked, and nocturnal hypoxemia 16 to determine whether associations were independent of these parameters.
All significance levels reported were 2-sided, and all analyses were conducted using SAS version 9.4 (SAS Institute, Inc., Cary, NC).
RESULTS
Characteristics of Study Population
This analytical cohort comprised 2,754 primarily Caucasian (90.8%) men with an average age of 76.0 AE 5.3 at the Sleep Visit.
We examined characteristics of participants according to quartile of amplitude. On average, younger age, lower BMI, and more hours spent working were associated with higher (e.g., more favorable) amplitude values. The proportions of men with an IADL impairment, a comorbid condition, benzodiazepine use, antidepressant use, depression, and nocturnal hypoxemia decreased as amplitude increased. Greater alcohol and caffeine consumption, physical activity, self-reported health, and sleep efficiency were associated with higher amplitude (Table 1) . Participants did not significantly differ across quartiles of amplitude in education, current smoking, or use of sleep medications (data not shown). Participant characteristics are presented according to acrophase in Supplementary Table S1 .
Longitudinal Association Between RAR Parameters and Cognitive Decline
By Visit 2 (1.18 AE 0.32 years after the Sleep Visit), men had begun to show signs of cognitive decline, with an average decrease of 0.5 AE 4.6 points in 3MS score. This trend continued at Visit 3 (3.4 AE 0.5 years after Sleep Visit). The unadjusted average 3MS score was 1.3 AE 5.5 points lower than at the Sleep Visit. At Visit 3, 18.7% of men were considered to have cognitive decline (5-point decline in 3MS score).
The adjusted annualized changes in 3MS score are summarized according to RAR parameters in Figure 2 . Men with lower amplitude (quartile 1) had greater decline in 3MS score than those in quartile 4 (0.66-vs 0.45-point decline, p<.001). Similar associations were seen between mesor and 3MS decline (0.52-vs 0.22-point decline, p=.01) and between rhythm robustness (pseudo F-statistic) and 3MS decline (0.54-vs 0.30-point decline, p<.001). Acrophase was not associated with adjusted annualized change in 3MS score. Further adjustment for physical activity, sleep efficiency, nocturnal hypoxemia, or hours worked did not attenuate any associations (data not shown).
The associations between RAR measurements and clinically significant 3MS decline are shown in Table 2 and  Supplementary Table S2 . After multivariable adjustment, the odds of clinically significant cognitive decline were approximately 1.4 times greater with lower levels of amplitude and robustness (pseudo F-statistic). Results remained significant after adjustment for physical activity and hours worked. Significance was attenuated (p=.05) after adjustment for sleep efficiency for both predictors and for nocturnal hypoxemia for robustness. Compared to those with acrophase from 12:28 to 4:06 p.m., participants with acrophase <12:28 p.m. (phase advanced) had a 1.8-fold increase in odds of clinically significant cognitive decline as measured by 3MS. This association remained after adjustment for physical activity, sleep efficiency, hours worked, and nocturnal hypoxemia. Mesor was not associated with clinically significant decline.
The adjusted annualized changes in TMT-B time are summarized according to RAR parameters in Supplementary Figure S1 . Lower amplitude and phase-advanced acrophase were associated with significant worsening (prolongation) in TMT-B time (amplitude quartile 1: 3.97 s/y; quartile 4: 2.27 s/y, p=.007; acrophase < 12:28 p.m.: 
DISCUSSION
In this cohort of community-dwelling men aged 65 and older, we observed longitudinal associations between several RAR indices and cognitive decline after an average of 3.4 years of follow-up. Lower amplitude, mesor, and rhythm robustness (pseudo F-statistic) were associated with significant decline in 3MS score. Furthermore, men with lower amplitude and rhythm robustness and those with phase-advanced acrophase were more likely to develop clinically significant cognitive decline, as measured according to 3MS score. These associations were not attenuated after adjustment for numerous covariates related to health and lifestyle, although adjustment for sleep efficiency attenuated the associations between lower amplitude, as well as rhythm robustness, and likelihood of clinically significant cognitive decline. We also observed associations between lower amplitude and phase-advanced acrophase and worsening of TMT-B test time. Overall, these data support our hypothesis that disrupted circadian rhythms of activity are associated with cognitive decline.
Cognitive test results at the Sleep Visit were comparable with those of other studies of community-living adults without dementia. 35, 36 Participants in this cohort were considered cognitively healthy overall at the Sleep Visit, and associations between disrupted RAR and cognition became evident as cognition declined over time.
Few studies of community-dwelling older adults have examined longitudinal associations between measures of RAR and cognition, and to our knowledge, none have used the same rhythm parameters and longitudinal cognitive outcomes as the present study. Prospective analyses of sleep disturbances and risk of incident cognitive impairment have been largely based on self-report of sleep and have reported conflicting findings. [6] [7] [8] [9] 11, 12 . It is interesting to compare our findings with similar analyses using objectively measured activity rhythms. Fragmented RAR was negatively correlated with mental speed, memory, and cognitive function, independent of age, in men and women. 11 In a separate analysis of the MrOS cohort, lower daytime activity at baseline was associated with decreasing 3MS score and worsening performance on the TMT-B. 37 In older women, lower amplitude was associated with worsening TMT-B test performance and categorical fluency; lower mesor was associated with worsening categorical fluency. 13 Women with lower amplitude and pseudo F-statistic were more likely to develop dementia or MCI. 14 In contrast to the present study, phase-delayed acrophase has previously been associated with cognitive regression. Older adults with cognitive decline had later acrophase than those with intact cognition. 12 Elderly women with phase-delayed acrophase (>1 SD above the mean) performed worse on categorical fluency and were at greater risk of dementia and MCI after 5 years.
13,14 Sex, age, and different definitions of phase-delayed acrophase may account for the differences between these 12,14 and the present study. Factors such as sleep behavior, chronotype, and environmental exposures to light may also have differed between studies and influenced findings related to acrophase. Further research is needed.
Disturbances of the sleep-wake cycle, which are reflected in less-robust activity rhythms, are particularly pronounced in age-associated cognitive impairments, 38 delirium, 39 and neurodegenerative diseases, including Alzheimer's disease (AD). 40, 41 Shifts in activity phase in adults with dementia have been shown to predict shorter survival 41 and are hypothesized to be a primary cause of institutionalization. 42, 43 Chronotype has been shown to affect several cerebral mechanisms and cognitive processing; 44 bidirectional interactions between cognitive performance and circadian processes suggest that time of day is an important factor in a variety of cognitive tasks. 45 At the molecular level, multiple circadian oscillators (clock-related genes) have demonstrated different expression patterns across several brain regions in individuals with AD than in controls. 46 Furthermore, a pronounced age-related variation in the biosynthesis of vasopressin in the suprachiasmatic nucleus (SCN) may affect neurological function. 47 This study has a number of strengths, including a large sample size, use of validated outcome measures, and adjustment for multiple confounders. Participants in this prospective cohort were enrolled from the community and not selected based on sleep complaints or cognition, although participants were primarily healthy Caucasian men, so generalizability to other populations is limited. Because men unable to forgo using mechanical devices during sleep or nocturnal oxygen therapy were excluded from the study, results of this analysis are not generalizable to these individuals. Wrist actigraphy may be subject to masking by imposed schedules, 48 and, unlike melatonin or temperature rhythms, RAR does not directly assess SCN circadian output. 48 Actigraphy recordings were limited to approximately 5 days of assessment at one time point. Decline outcomes required men to have data from Visits 2 and 3, so those who died before these visits or were unable to attend were not included in the analysis. Adjustment for numerous covariates was performed, but the possibility of residual confounding remains. Finally, it was difficult to observe the full spectrum of associations between RAR and cognitive function because of the low prevalence of severely disrupted circadian rhythms in this cohort.
Results of the present analysis require confirmation in other longitudinal cohort analyses but could inform future interventions designed to slow cognitive decline. Markers of circadian rhythm may be useful as prognostic indicators in identifying older adults at risk of cognitive impairment, but more research is needed. Others 49, 50 have used a nonparametric approach to analyze circadian data in humans; these methods have not yet been applied to MrOS data but could be explored in future analyses.
In this cohort of older community-dwelling men, disrupted RAR (lower amplitude, mesor, pseudo F-statistic, phase advanced acrophase) were associated with greater cognitive decline (as measured using 3MS score) over an average of 3.4 years. These findings contribute to a growing body of evidence suggesting that dysregulated RAR is associated with cognitive decline in older adults.
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